0. DOCID:30781 SCORE: 0.00373756591266423
DOCNO: 14567021
OWNER: NLM
STATUS: MEDLINE
DESCRIPTOR: Infusions, Parenteral
QUALIFIER: administration & dosage
QUALIFIER: pathology
QUALIFIER: drug therapy
QUALIFIER: surgery
AUTHOR: Wansik Yu W
AFFILIATION: School of Medicine, Kyungpook National University Hospital, 50 Samduk-dong Taegu, 700-721, South Korea. wyu@knu.ac.kr
PUBTYPE: Journal Article
PUBTYPE: Review
JOURNALTITLE: Surgical oncology clinics of North America.
COUNTRY: United States
TITLE: Impact of perioperative intraperitoneal chemotherapy on the treatment of primary gastric cancer.
PUBDATE: 20030701
Perioperative intraperitoneal chemotherapy provides effective prevention of peritoneal recurrence after resection in advanced gastric cancer, especially in gastric cancer with serosal invasion. With improved local-regional control, improved survival rate for advanced gastric cancer is achieved. This type of regional chemotherapy is an independent treatment-related prognostic factor for advanced gastric cancer. There are several methods of perioperative intraperitoneal chemotherapy. Among them, early postoperative intraperitoneal chemotherapy is simple and easy to perform.


1. DOCID:30767 SCORE: 0.00373755058894656
DOCNO: 12073635
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: diagnosis
QUALIFIER: diagnostic use
QUALIFIER: diagnosis
QUALIFIER: diagnosis
AUTHOR: Takashi Ohata T
AUTHOR: Yoshinao Abe Y
AUTHOR: Tomisato Miura T
AUTHOR: Tatsusuke Sato T
AFFILIATION: Department of Radiology, Hirosaki University School of Medicine.
PUBTYPE: Journal Article
JOURNALTITLE: Nippon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica.
COUNTRY: Japan
TITLE: [An experimental study for tumor detection by indocyanine green with near-infrared topography]
PUBDATE: 20020501
We studied tumor detection by indocyanine green (ICG) with near-infrared topography in rat experimental tumors: hepatoma AH109A and osteosarcoma POB 102. Time-intensity curves and topograms after ICG injection were obtained in tumors and surrounding normal tissues. Intensities in tumors were slowly reduced, and intensities in normal tissues were rapidly reduced, resulting in positive tumor image in topogram. It is concluded that near-infrared topography enhanced by ICG is useful for cancer detection.


2. DOCID:31139 SCORE: 0.00364695282719594
DOCNO: 15485322
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: drug therapy
QUALIFIER: radiotherapy
AUTHOR: Boaz Weisz B
AUTHOR: Dror Meirow D
AUTHOR: Eyal Schiff E
AUTHOR: Michael Lishner M
AFFILIATION: Department of Obstetrics and Gynecology, Sheba Medical Center, Tel-Hashomer, Israel. boazmd@inter.net.il
PUBTYPE: Journal Article
PUBTYPE: Review
JOURNALTITLE: Expert review of anticancer therapy.
COUNTRY: England
TITLE: Impact and treatment of cancer during pregnancy.
PUBDATE: 20041001
Cancer is the second most common cause of death in the reproductive years and complicates up to one in 1000 pregnancies. When cancer is diagnosed during pregnancy, the management strategy must take into account both the mother and developing fetus. In this article, the four most common malignancies diagnosed in pregnant patients--cervical and breast cancer, malignant melanoma and lymphoma--will be reviewed, with an emphasis on the impact of the diagnosis and management on the pregnant patient and the developing fetus.


3. DOCID:31097 SCORE: 0.00364694325801239
DOCNO: 12833614
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: therapy
AUTHOR: V A Kikot' VA
PUBTYPE: Evaluation Studies
PUBTYPE: Journal Article
JOURNALTITLE: Klinichna khirurhiia / Ministerstvo okhorony zdorov'ia Ukraïny, Naukove tovarystvo khirurhiv Ukraïny.
COUNTRY: Ukraine
TITLE: [Comparative effectiveness of various methods of surgical, combined and comprehensive treatment of patients with colonic cancer]
PUBDATE: 20030301
The results of radical treatment of cancer recti using surgical and combined methods, which had envisaged application of preoperative irradiation, systemic chemotherapy with the add of fluorouracil and calcium folinate, intraarterial polychemotherapy with the help of fluorouracil, adriablastinum on background of verapamil, endolymphatic polychemotherapy with local hyperthermy of ultra-high frequency, intraoperative intraperitoneal polychemotherapy and autoimmunotherapy with application of antitumoral vaccine. After application of autoimmunotherapy, endolymphatic polychemotherapy, preoperative intensive gamma-therapy in combined treatment of patients with cancer recti II-III stages the indexes of five-year survival had improved.


4. DOCID:25906 SCORE: 0.00320976388752809
DOCNO: 10193595
AUTHOR: B A Johnson BA
AFFILIATION: Hamot Family Practice Residency Program, Erie, Pennsylvania, USA.
PUBTYPE: Corrected and Republished Article
PUBTYPE: Journal Article
PUBTYPE: Review
JOURNALTITLE: American family physician.
COUNTRY: UNITED STATES
TITLE: Flexible sigmoidoscopy: screening for colorectal cancer.
PUBDATE: 19990301
Flexible sigmoidoscopy is an important screening procedure because of its ability to detect early changes in the distal colon. The 60-cm flexible sigmoidoscope provides excellent visualization with minimal discomfort to patients. Successful sigmoidoscopy requires adequate patient preparation, proper equipment and an experienced examiner who can recognize both normal and abnormal findings. Complications arising from sigmoidoscopy are rare, but patients may experience some cramping, gas or watery stools. Screening and primary preventive measures, including regular exercise and increased dietary fiber intake, can lower the morbidity and mortality associated with colorectal cancer.


5. DOCID:27999 SCORE: 0.00320850940057698
DOCNO: 12057053
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: therapy
AUTHOR: S K Gibbons SK
AUTHOR: H M Keys HM
AFFILIATION: Department of Radiation Oncology, MC-95, Albany Medical Center, 43 New Scotland Avenue, Albany, NY 12208, USA.
PUBTYPE: Journal Article
PUBTYPE: Review
JOURNALTITLE: Current treatment options in oncology.
COUNTRY: United States
TITLE: Advanced cervical cancer.
PUBDATE: 20000601
Several large, prospectively randomized clinical trials run by multi-institutional cooperative groups have established that the best treatment for advanced cancer of the cervix is primary radiotherapy with concurrent, cisplatin-based chemotherapy. In fact, patients with earlier stage cervix cancer with poor prognostic indicators (large, bulky tumors, positive pelvic lymph nodes, or unexpected parametrial disease at the time of surgery) also show a survival benefit with this approach. Adequate radiation dosing (both external beam and intracavitary) is essential. The additional benefit of periaortic lymph node irradiation is debated, but generally accepted, for patients with locally advanced disease or pelvic lymph node involvement.


6. DOCID:30574 SCORE: 0.00317903072248256
DOCNO: 12478855
OWNER: NLM
STATUS: MEDLINE
DESCRIPTOR: Mastectomy, Segmental
QUALIFIER: therapeutic use
QUALIFIER: surgery
AUTHOR: Takashi Fukutomi T
AFFILIATION: National Cancer Center Hospital, Breast Surgery Division, Tokyo, Japan.
PUBTYPE: Journal Article
JOURNALTITLE: Nippon Geka Gakkai zasshi.
COUNTRY: Japan
TITLE: [Option of the surgical mode for breast cancer based on the effect of neoadjuvant chemotherapy]
PUBDATE: 20021101
Neoadjuvant chemotherapy has become standard treatment for breast cancer patients to avoid mastectomy in larger tumors. Neoadjuvant chemotherapy permits more breast-conserving surgery to be performed. The treatment outcome is favorable in women whose tumors show a complete pathological response. Histological grade, HER-2, p53, and hormone receptor status are significant predictive factors of a good pathological response to neoadjuvant chemotherapy. In addition, computed tomography and/or magnetic resonance imaging are useful tools in determining the optimal resection area for breast cancer.


7. DOCID:30555 SCORE: 0.00317902097171174
DOCNO: 12170885
OWNER: NLM
STATUS: MEDLINE
DESCRIPTOR: Paraneoplastic Syndromes
DESCRIPTOR: Skin Diseases
AUTHOR: Sarah Boyce S
AUTHOR: Julie Harper J
AFFILIATION: Department of Dermatology, University of Alabama at Birmingham, EFH, Suite 414, Birmingham, AL 35294, USA.
PUBTYPE: Journal Article
PUBTYPE: Review
JOURNALTITLE: Dermatologic clinics.
COUNTRY: United States
TITLE: Paraneoplastic dermatoses.
PUBDATE: 20020701
Skin manifestations of systemic disease and malignancy are protean. The recognition of a potentially paraneoplastic dermatosis as such must prompt an investigation for occult malignancy. Lack of familiarity with cutaneous clues of internal malignancy may delay diagnosis and treatment of cancer. It is important to consider a paraneoplastic process in the differential diagnosis of a number of eruptive and treatment-resistant dermatoses. These dermatoses may be the first sign of an occult neoplasm. Their recognition may assist in cancer detection and the swift induction of appropriate therapy.


8. DOCID:27969 SCORE: 0.00317697610894408
DOCNO: 11147228
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: drug therapy
AUTHOR: R A Larson RA
AFFILIATION: Section of Hematology/Oncology, Department of Medicine and Cancer Research Center, University of Chicago, Chicago, Ilinois, USA. rlarson@medicine.bsd.uchicago.edu
PUBTYPE: Journal Article
PUBTYPE: Review
JOURNALTITLE: Hematology/oncology clinics of North America.
COUNTRY: United States
TITLE: Recent clinical trials in acute lymphocytic leukemia by the Cancer and Leukemia Group B.
PUBDATE: 20001201
The Cancer and Leukemia Group B (CALGB) has performed a series of studies evaluating different aspects of remission induction and postremission treatment in adults with acute lymphocytic leukemia (ALL). In recent years, these clinical trials have been supplemented by systematic morphologic, immunophenotyping, cytogenetic, and molecular genetic studies leading to the identification of different risk groups of patients who may warrant individualized treatments. These protocols have enrolled all adult patients older than 15 years with ALL, without an upper age restriction, and did not exclude Philadelphia (Ph) chromosome-positive patients.


9. DOCID:27924 SCORE: 0.00317695871216401
DOCNO: 10783521
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: pharmacology
QUALIFIER: drug therapy
QUALIFIER: pharmacology
AUTHOR: R Schlemmer R
AUTHOR: T Spruss T
AUTHOR: G Bernhardt G
AUTHOR: H Schönenberger H
AFFILIATION: Lehrstuhl für Pharmazeutische Chemie II, Universität Regensburg, Germany.
PUBTYPE: Journal Article
JOURNALTITLE: Archiv der Pharmazie.
COUNTRY: GERMANY
TITLE: Does [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]- dichloroplatinum(II) act on the hormone-sensitive, murine breast cancer as a biological response modifier? Part 1: The MXT-M-3.2 breast cancer stimulates the growth of an identical second graft; [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]dichloroplat inum (II) inhibits this process.
PUBDATE: 20000301
The MXT-M-3.2 breast cancer implanted into female B6D2F1 mice accelerates the growth of an identical second tumor. This process is inhibited by [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl) ethylenediamine]dichloroplatinum(II). The possible modes of action of this compound as a biological response modifier are discussed.


10. DOCID:31015 SCORE: 0.00312798978205974
DOCNO: 15086060
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: diagnosis
QUALIFIER: therapy
AUTHOR: Philippe Rougier P
AUTHOR: Marie-Christine Clavero-Fabri MC
AUTHOR: Emmanuel Mitry E
AFFILIATION: Hépato-gastro-entérologie, oncologie digestive, hôpital Ambroise Paré, 92104 Boulogne. philippe.rougier@apr.ap-hop-paris.fr
PUBTYPE: Journal Article
JOURNALTITLE: La Revue du praticien.
COUNTRY: France
TITLE: [Colorectal cancer management]
PUBDATE: 20040101
Colorectal cancer is a frequent disease with an increasing incidence. Its prognosis improved recently because of progress in diagnostic and therapeutic procedures. Rationale and guidelines for colorectal cancer screening using the faecal occult blood test in the average risk population and screening recommendations for high risk groups are presented, as well as diagnostic and therapeutic principles. Because of the efficacy of the new chemotherapy regimens, the availability of biotherapies and the fact that surgery can potentially cure more and more patients, colorectal cancer management needs to be multidisciplinary.


11. DOCID:30963 SCORE: 0.00312797327983675
DOCNO: 14748379
OWNER: NLM
STATUS: MEDLINE
DESCRIPTOR: Neoplasms
AUTHOR: K Govind Babu KG
AFFILIATION: Kidwai Memorial Institute of Oncology, Bangalore 560029.
PUBTYPE: Journal Article
JOURNALTITLE: Journal of the Indian Medical Association.
COUNTRY: India
TITLE: Cancer in the elderly.
PUBDATE: 20030701
Cancer, the dreaded killer disease, has its aetiology in several factors like genetic, environmental, diet habits, etc. Age over 65 years is generally considered elderly and the cancer incidence increases with age. Cancer is second to cardiovascular disease for the cause of death in the elderly. The behaviour of certain cancers also differ in the elderly thus adding to the ultimate outcome that is usually confounded by several comorbid illnesses. The prognostic factor varies with type of cancer. Older patients with Hodgkin's disease and acute myeloid leukaemia do worse than breast cancer. Radiation therapy is well tolerated by the elderly.


12. DOCID:27730 SCORE: 0.00310202309589073
DOCNO: 9808633
OWNER: NLM
STATUS: MEDLINE
DESCRIPTOR: Anticarcinogenic Agents
QUALIFIER: prevention & control
QUALIFIER: therapeutic use
AUTHOR: C Ip C
AFFILIATION: Department of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Buffalo, NY 14263, USA.
PUBTYPE: Journal Article
PUBTYPE: Review
JOURNALTITLE: The Journal of nutrition.
COUNTRY: UNITED STATES
TITLE: Lessons from basic research in selenium and cancer prevention.
PUBDATE: 19981101
The article reviews the progress in basic research of selenium and cancer prevention during the past decade. Special emphasis is placed on the following four major areas of discussion: 1) chemical forms of selenium and anticarcinogenic activity; 2) selenium-enriched food; 3) in vitro effects of selenite vs. monomethylated selenium; and 4) aromatic selenium compounds. It is clear that basic research has contributed new knowledge to our understanding of selenium biochemistry, anticancer efficacy and regulation of cell growth. Some of this information could be ready for incorporation into the design of a second-generation selenium trial in humans.


13. DOCID:31136 SCORE: 0.00305455007226111
DOCNO: 16340833
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: complications
QUALIFIER: etiology
AUTHOR: J-M Bréchot JM
AFFILIATION: Service d'Oncologie Médicale, Hôpital Avicenne, Bobigny, France. anne-marie.brechot@avc.ap-hop-paris.fr
PUBTYPE: Journal Article
PUBTYPE: Review
JOURNALTITLE: Revue des maladies respiratoires.
COUNTRY: France
TITLE: [Thrombosis and lung cancer]
PUBDATE: 20051201
Venous thromboembolism (TE) is a frequent occurrence in lung cancer patients and can be precipitated by venous stasis, the activation of clotting cascades by pro-coagulant tumour factors and by vascular injury due to chemotherapy and central venous catheters. Subcutaneous low molecular weight heparin (LMWH) has replaced intravenous unfractionated heparin in the treatment of acute TE. The use of long-term LMWH is recommended to prevent the recurrence of TE. Prophylactic treatment is indicated in patients undergoing surgery or hospitalised. Heparin appears to have distinct anti-neoplastic as well as anticoagulant effects, which benefit overall survival.


14. DOCID:31044 SCORE: 0.00305451079339094
DOCNO: 16266573
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: diagnosis
AUTHOR: Niels Christian Bjerregaard NC
AUTHOR: Søren Laurberg S
AFFILIATION: Arhus Universitetshospital, Arhus Sygehus, Kirurgisk Afdeling L, Arhus C. rlg07ncb@as.aaa.dk
PUBTYPE: Journal Article
JOURNALTITLE: Ugeskrift for laeger.
COUNTRY: Denmark
TITLE: [Diagnostic strategy with respect to symptoms of colorectal cancer]
PUBDATE: 20051001
In relation to the risk of colorectal cancer, the population is divided into high-risk and average-risk groups. Patients at high risk are followed according to the national recommendations. Patients at average risk are examined according to their primary symptom(s). The strategy is based on the diagnostic strategy described in a Danish Health Technology Assessment published in 2001. The article states the recommendations for the high- risk groups and describes the value of the individual primary symptoms of colorectal cancer for average-risk patients and the examinations recommended accordingly.